Not logged in Share Save
Share Save
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma Cloyd, Jordan M.; Sarna, Angela; Arango, Matthew J.; Bates, Susan E.; Bhutani, Manoop S.; Bloomston, Mark; Chung, Vincent; Dotan, Efrat; Ferrone, Cristina R.; Gambino, Patricia F.; Goenka, Ajit H.; Goodman, Karyn A.; Hall, William A.; He, Jin; Hogg, Melissa E.; Jayaraman, Shiva; Kambadakone, Avinash; Katz, Matthew H. G.; Khorana, Alok A.; Ko, Andrew H.; Koay, Eugene J.; Kooby, David A.; Krishna, Somashekar G.; Larsson, Liliana K.; Lee, Richard T.; Maitra, Anirban; Massarweh, Nader N.; Mikhail, Sameh; Muzaffar, Mahvish; O'Reilly, Eileen M.; Palta, Manisha; Petzel, Maria Q. B.; Philip, Philip A.; Reyngold, Marsha; Santa Mina, Daniel; Sohal, Davendra P. S.; Sundaresan, Tilak K.; Tsai, Susan; Turner, Kea L.; Vreeland, Timothy J.; Walston, Steve; Washington, M. Kay; Williams, Terence M.; Wo, Jennifer Y.; Snyder, Rebecca A. Share Save
Start low, go slow, a strategy to tailor treatment dosing in older or vulnerable adults with advanced solid cancer: A systematic review and meta-analysis Aleixo, Gabriel; Patel, Tej; Ani, Julianne; Ferrell, Will J.; Dotan, Efrat; Takvorian, Samuel U.; Williams, Grant R.; Parikh, Ravi B.; Sedhom, Ramy Share Save
Tumor-agnostic efficacy and safety of lirafugratinib, a highly selective FGFR2 inhibitor, in patients (pts) with advanced solid tumors with FGFR2 fusions or rearrangements (f/r): the ReFocus study Hollebecque, A.; Dotan, E.; Liao, C. Y. A.; Roda, D.; Fontana, E.; Babiker, H.; Kim, R. D.; Oh, D. Y.; Ghiringhelli, F.; Moreno, I.; Liu, J.; Subbiah, V.; Varkaris, A.; Borad, M. J.; Cassier, P. A.; Deary, A.; Ramirez, F. T.; Ricard, F.; Jen, K. Y.; Schram, A. M. Share Save
Share Save
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202 Vogel, A.; Sahai, V.; Hollebecque, A.; Vaccaro, G. M.; Melisi, D.; Al Rajabi, R. M.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; Oh, D. -Y.; Dotan, E.; V. Catenacci, D.; Van Cutsem, E.; Lihou, C. F.; Zhen, H.; Veronese, M. L.; Abou-Alfa, G. K. Share Save
Early Discontinuation of Adjuvant Chemotherapy in Older Adults with Early Breast Cancer: Results from the Prospective Multicenter HOPE Study Ji, Jingran; Sun, Canlan; Freedman, Rachel; Cohen, Harvey; Klepin, Heidi; Tew, William; Moy, Beverly; Chapman, Andrew; Wildes, Tanya; Dotan, Efrat; Magnuson, Allison; O'Connor, Tracey; Fenton, Mary Anne; Kim, Heeyoung; Katheria, Vani; Gross, Cary; Muss, Hyman; Sedrak, Mina Share Save
Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study Sedrak, Mina S.; Sun, Can-Lan; Bae, Marie; Freedman, Rachel A.; Magnuson, Allison; O'Connor, Tracey; Moy, Beverly; Wildes, Tanya M.; Klepin, Heidi D.; Chapman, Andrew E.; Tew, William P.; Dotan, Efrat; Fenton, Mary Anne; Kim, Heeyoung; Katheria, Vani; Muss, Hyman B.; Cohen, Harvey J.; Gross, Cary P.; Ji, Jingran Share Save
Share Save
Phase 1 study of Zanidatamab Zovodotin (ZW49): Safety Profile and Recommended Dose (RD) in patients with Human Epidermal Growth Factor 2 (HER2)-positive solid cancers Oh, Do-Youn; Bedard, Philippe L.; Lee, Keun-Wook; Han, Hyo Sook; Kang, Yoon-Koo; Miller, Wilson H.; Rha, Sun Young; Kim, Jwa Hoon; Dotan, Efrat; Liao, Chih-Yi; Tolcher, Anthony; Spira, Alexander; Hamilton, Erika; Karapetis, Christos; Boyken, Lisa; Chen, Charles; Woolery, Joseph; Jhaveri, Komal Share Save
Clinical activity of lirafugratinib (RLY-4008), a highly selective FGFR2 inhibitor, in patients with advanced FGFR2-altered solid tumors: The ReFocus study Schram, Alison M.; Subbiah, Vivek; Liao, Chih-Yi (Andy); Moreno, Victor; Desamparados, Roda; Ponz-Sarvise, Mariano; Dotan, Efrat; Cassier, Philippe Alexandre; Moreno, Irene; Varkaris, Andreas; Kim, Richard D.; Garralda, Elena; Opdam, Frans; Tai, David; Italiano, Antoine; Oh, Do-Youn; Goyal, Lipika; Fontana, Elise; Liu, Jia; Boukovala, Myrto; Ghiringelli, Francois; Borad, Mitesh J.; Babiker, Hani; Jin, Zhaohui; Millward, Michael; Yachnin, Jeffrey; Kamath, Suneel Deepak; Coward, Jermaine M.; Yoo, Changhoon; Kelley, Robin Kate; Sahai, Vaibhav; Bridgewater, John; Springfield, Christoph; Florou, Vaia; El-Khoueiry, Anthony; Eskens, Ferry; Lin, Bruce; Paulson, Scott; Curigliano, Giuseppe; Murphy, Meredith; Deary, Alicia; Ricard, Fabien; Jen, Kai Yu; Ramirez, Florence (Tianhui); Blakesley, Rick E.; Schmidt-Kittler, Oleg; Mar, Brenton G.; Park, Joon Oh; Hollebecque, Antoine Share Save
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial Ji, Jingran; Bae, Marie; Sun, Can-Lan; Wildes, Tanya M.; Freedman, Rachel A.; Magnuson, Allison; O'Connor, Tracey; Moy, Beverly; Klepin, Heidi D.; Chapman, Andrew E.; Tew, William P.; Dotan, Efrat; Fenton, Mary Anne; Kim, Heeyoung; Katheria, Vani; Gross, Cary P.; Cohen, Harvey J.; Muss, Hyman B.; Sedrak, Mina S. Share Save
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors Zibelman, Matthew; MacFarlane, Alexander W.; Costello, Kimberly; McGowan, Thomas; O'Neill, John; Kokate, Rutika; Borghaei, Hossein; Denlinger, Crystal S.; Dotan, Efrat; Geynisman, Daniel M.; Jain, Angela; Martin, Lainie; Obeid, Elias; Devarajan, Karthik; Ruth, Karen; Alpaugh, R. Katherine; Dulaimi, Essel Al-Saleem; Cukierman, Edna; Einarson, Margret; Campbell, Kerry S.; Plimack, Elizabeth R. Share Save
Ampullary Adenocarcinoma, Version 1.2023 Chiorean, E. Gabriela; Del Chiaro, Marco; Tempero, Margaret A.; Malafa, Mokenge P.; Benson, Al B., III; Cardin, Dana B.; Christensen, Jared A.; Chung, Vincent; Czito, Brian; Dillhoff, Mary; Donahue, Timothy R.; Dotan, Efrat; Fountzilas, Christos; Glazer, Evan S.; Hardacre, Jeffrey; Hawkins, William G.; Klute, Kelsey; Ko, Andrew H.; Kunstman, John W.; LoConte, Noelle; Lowy, Andrew M.; Masood, Ashiq; Moravek, Cassadie; Nakakura, Eric K.; Narang, Amol K.; Nardo, Lorenzo; Obando, Jorge; Polanco, Patricio M.; Reddy, Sushanth; Reyngold, Marsha; Scaife, Courtney; Shen, Jeanne; Truty, Mark J.; Vollmer, Charles, Jr.; Wolff, Robert A.; Wolpin, Brian M.; McCullough, Beth; Lubin, Senem; Darlow, Susan D. Share Save
Share Save
The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluoro- uracil, leucovorin, and liposomal irinotecan in older patients with treatment-na?ve metastatic pancreatic cancer- defining a new treatment option for older vulnerable patients Dotan, Efrat; Catalano, Paul; Lenchik, Leon; Boutin, Robert; Yao, Xin; Marques, Helga S.; Ioffe, Dina; Zhen, David B.; Li, Daneng; Wagner, Lynne I.; Simon, Melissa A.; Wong, Terence Z.; 'Dwyer, Peter J. O. Share Save
Share Save
Initial results of a cohort of advanced pancreatic cancer patients in a phase 1b Study of NGM120, a first-in-class anti-GDNF Family Receptor Alpha Like (GFRAL) antibody Hendifar, Andrew; Dotan, Efrat; Weinberg, Benjamin; Kim, Edward; Hosein, Peter; Luo, Jian; Zha, Jiping; DePaoli, Alex; Hanes, Vladimir; Tranmuchowski, Cecilia; Zhou, Kefei; Tseng, Carol; Lieu, Hsiao Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
